Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $9.05 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.31.
Market Cap
9.05T
Revenue
4.67T
Profits
191.22B
PE Ratio
47.31
Profit Margin
4.10%
Dividend Yield
0.39%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | -0.61% | 2,054,753 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 617.01B | -1.02% | 10,942,147 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 464.43B | 1.11% | 5,863,069 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 356.01B | 0.34% | 9,661,871 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 333.82B | 1.83% | 3,310,329 | 450.53B |
| 6 | NVS | Novartis AG | 266.66B | -0.04% | 2,246,668 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 243.58B | -0.51% | 3,035,561 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 242.11B | 0.35% | 1,667,702 | 46.34B |
| 9 | AMGN | Amgen Inc. | 217.90B | -1.04% | 3,510,313 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 179.47B | -1.87% | 5,044,221 | 30.46B |
| 11 | ABT | Abbott Laboratories | 168.71B | 0.84% | 8,709,933 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 165.74B | -0.21% | 10,261,231 | 50.34B |
| 13 | PFE | Pfizer Inc. | 158.45B | -1.14% | 35,007,894 | 63.70B |
| 14 | DHR | Danaher Corporation | 150.48B | 1.09% | 3,915,873 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 138.47B | -2.32% | 1,833,944 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 127.93B | -0.40% | 939,659 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 124.91B | 0.53% | 9,935,527 | 49.19B |
| 18 | CVS | CVS Health Corporation | 110.58B | 1.48% | 10,463,758 | 412.65B |
| 19 | MDT | Medtronic plc | 110.49B | -0.07% | 35,366,014 | 37.54B |
| 20 | SYK | Stryker Corporation | 105.65B | 0.90% | 1,995,385 | 25.84B |
| 21 | MCK | McKesson Corporation | 105.20B | 0.38% | 777,049 | 410.98B |
| 22 | SNY | Sanofi | 95.48B | -1.84% | 4,335,105 | 55.89B |
| 23 | GSK | GSK plc | 94.34B | -0.32% | 5,386,360 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.38B | 0.78% | 929,810 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 83.80B | 1.25% | 892,683 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 75.86B | 0.57% | 10,289,461 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 73.41B | 0.05% | 613,950 | 15.53B |
| 28 | CI | The Cigna Group | 71.48B | 0.96% | 1,914,065 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 61.74B | -1.46% | 18,313,944 | 21.00B |
| 30 | NTRA | Natera, Inc. | 59.15B | 0.46% | 2,156,456 | 2.71B |
| 31 | COR | Cencora, Inc. | 58.98B | -0.24% | 1,164,368 | 332.77B |
| 32 | ARGX | argenx SE | 57.39B | -1.79% | 333,880 | 5.32B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 57.13B | - | 2,132,769 | 28.42B |
| 34 | CAH | Cardinal Health, Inc. | 52.86B | -0.78% | 1,860,046 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 49.08B | -0.05% | 2,408,378 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 48.16B | -0.71% | 1,865,274 | 22.48B |
| 37 | A | Agilent Technologies, Inc. | 47.30B | 0.66% | 2,290,116 | 7.37B |
| 38 | MDLN | Medline Inc. | 46.82B | 1.92% | 13,269,508 | 29.94B |
| 39 | HUM | Humana Inc. | 46.63B | 2.29% | 765,061 | 145.68B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 46.06B | 0.56% | 4,774,988 | 17.32B |
| 41 | RVMD | Revolution Medicines, Inc. | 44.29B | 0.36% | 1,570,495 | - |
| 42 | VEEV | Veeva Systems Inc. | 44.25B | -3.05% | 1,081,784 | 3.46B |
| 43 | IQV | IQVIA Holdings Inc. | 42.50B | -0.96% | 1,366,640 | 16.98B |
| 44 | WAT | Waters Corporation | 41.78B | -0.08% | 625,602 | 4.64B |
| 45 | ILMN | Illumina, Inc. | 41.23B | 2.75% | 2,835,992 | 4.49B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 40.84B | 0.12% | 288,816 | 4.55B |
| 47 | ONC | BeOne Medicines AG | 40.71B | -0.20% | 505,173 | 6.13B |
| 48 | HLN | Haleon plc | 38.26B | 0.92% | 22,385,301 | 14.80B |
| 49 | RPRX | Royalty Pharma plc | 32.87B | -0.82% | 2,229,485 | 2.54B |
| 50 | BIIB | Biogen Inc. | 32.49B | -1.32% | 780,428 | 10.03B |
| 51 | DXCM | DexCom, Inc. | 32.21B | -1.01% | 2,204,391 | 4.97B |
| 52 | CNC | Centene Corporation | 31.12B | 3.28% | 3,580,098 | 180.30B |
| 53 | ALC | Alcon Inc. | 30.80B | -0.28% | 1,274,346 | 10.86B |
| 54 | RMD | ResMed Inc. | 30.78B | -1.02% | 898,889 | 5.65B |
| 55 | MTD | Mettler-Toledo International Inc. | 29.78B | 0.34% | 129,329 | 4.13B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.40B | -4.96% | 1,661,854 | 4.80B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 29.04B | 0.48% | 3,243,885 | 21.27B |
| 58 | ZTS | Zoetis Inc. | 28.80B | 0.85% | 5,260,390 | 9.53B |
| 59 | ROIV | Roivant Sciences Ltd. | 25.80B | 0.62% | 4,365,825 | 7.53M |
| 60 | DGX | Quest Diagnostics Incorporated | 25.75B | 0.97% | 1,100,863 | 11.56B |
| 61 | WST | West Pharmaceutical Services, Inc. | 25.69B | -0.01% | 473,017 | 3.33B |
| 62 | LH | Labcorp Holdings Inc. | 25.02B | 1.28% | 588,225 | 14.35B |
| 63 | BNTX | BioNTech SE | 24.34B | 0.05% | 696,033 | 3.03B |
| 64 | INSM | Insmed Incorporated | 24.27B | 2.33% | 4,136,266 | 1.14B |
| 65 | GH | Guardant Health, Inc. | 23.86B | 1.75% | 1,650,849 | 1.18B |
| 66 | PHG | Koninklijke Philips N.V. | 23.40B | 0.46% | 836,268 | 20.18B |
| 67 | INCY | Incyte Corporation | 23.37B | -1.57% | 2,170,193 | 5.82B |
| 68 | UTHR | United Therapeutics Corporation | 23.23B | -5.19% | 1,117,875 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 20.82B | 1.83% | 574,588 | 21.81B |
| 70 | STE | STERIS plc | 20.33B | -0.38% | 676,532 | 6.04B |
| 71 | GMAB | Genmab A/S | 20.32B | 0.58% | 5,436,431 | 4.13B |
| 72 | VTRS | Viatris Inc. | 20.22B | 0.80% | 7,526,177 | 14.74B |
| 73 | RVTY | Revvity, Inc. | 16.91B | 1.66% | 1,236,577 | 2.91B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 16.84B | 0.26% | 1,985,371 | 8.51B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.73B | 0.23% | 303,678 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.30B | 1.14% | 636,628 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 14.96B | 0.25% | 641,436 | 1.20B |
| 78 | SOLV | Solventum Corporation | 14.95B | 0.09% | 880,453 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.55B | 1.76% | 1,648,262 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.47B | 0.78% | 1,969,280 | 2.44B |
| 81 | CRL | Charles River Laboratories International, Inc. | 13.85B | 1.17% | 445,516 | 4.00B |
| 82 | TEM | Tempus AI, Inc. | 13.83B | 0.17% | 5,692,291 | 1.43B |
| 83 | SMMT | Summit Therapeutics Inc. | 13.37B | 0.39% | 5,196,190 | - |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.15B | 0.51% | 2,646,295 | 713.07M |
| 85 | CORT | Corcept Therapeutics Incorporated | 12.56B | 1.93% | 960,162 | 830.81M |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.55B | 5.22% | 3,197,085 | 14.37B |
| 87 | PEN | Penumbra, Inc. | 12.51B | -0.14% | 239,681 | 1.50B |
| 88 | ICLR | ICON Public Limited Company | 12.50B | 0.12% | 676,144 | 8.29B |
| 89 | HALO | Halozyme Therapeutics, Inc. | 12.47B | 2.73% | 2,599,778 | 1.66B |
| 90 | TXG | 10x Genomics, Inc. | 12.18B | 5.34% | 3,147,228 | 616.91M |
| 91 | BAX | Baxter International Inc. | 12.14B | -0.63% | 4,808,263 | 11.47B |
| 92 | TWST | Twist Bioscience Corporation | 11.83B | 0.33% | 2,082,084 | 431.80M |
| 93 | EHC | Encompass Health Corporation | 11.82B | 0.62% | 1,114,806 | 6.21B |
| 94 | FMS | Fresenius Medical Care AG | 11.80B | -0.04% | 478,548 | 22.19B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.54B | -0.06% | 289,234 | 1.28B |
| 96 | DVA | DaVita Inc. | 11.40B | 1.33% | 451,962 | 14.01B |
| 97 | TECH | Bio-Techne Corporation | 11.35B | - | 1,866,663 | 1.22B |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 11.07B | -2.16% | 2,192,505 | 3.41B |
| 99 | ELAN | Elanco Animal Health Incorporated | 11.06B | 1.70% | 5,000,717 | 5.02B |
| 100 | SNN | Smith & Nephew plc | 11.01B | 0.53% | 1,228,402 | 6.30B |
| 101 | IBRX | ImmunityBio, Inc. | 10.90B | 10.83% | 31,251,554 | 165.79M |
| 102 | COO | The Cooper Companies, Inc. | 10.82B | -0.87% | 3,310,057 | 4.24B |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.38B | - | 3,801,168 | 3.50B |
| 104 | AVTR | Avantor, Inc. | 10.38B | 2.06% | 6,149,101 | 6.56B |
| 105 | UHS | Universal Health Services, Inc. | 10.36B | 0.37% | 597,956 | 18.11B |
| 106 | RGEN | Repligen Corporation | 10.25B | 2.52% | 1,460,472 | 785.10M |
| 107 | ALGN | Align Technology, Inc. | 10.21B | -1.11% | 549,998 | 4.14B |
| 108 | GMED | Globus Medical, Inc. | 10.15B | 1.60% | 1,310,453 | 3.14B |
| 109 | ENSG | The Ensign Group, Inc. | 9.93B | 1.27% | 356,162 | 5.49B |
| 110 | MOH | Molina Healthcare, Inc. | 9.87B | 4.81% | 625,098 | 42.47B |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 9.87B | 3.82% | 223,646 | 2.59B |
| 112 | GKOS | Glaukos Corporation | 9.65B | 0.36% | 742,806 | 612.84M |
| 113 | BRKR | Bruker Corporation | 9.64B | 2.10% | 2,227,602 | 3.50B |
| 114 | OSCR | Oscar Health, Inc. | 9.54B | 3.48% | 3,910,198 | 15.32B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.54B | -0.93% | 425,676 | 440.48M |
| 116 | HSIC | Henry Schein, Inc. | 9.46B | -0.06% | 1,132,885 | 13.60B |
| 117 | AXSM | Axsome Therapeutics, Inc. | 9.39B | -1.55% | 981,379 | 776.57M |
| 118 | QGEN | Qiagen N.V. | 9.25B | 6.45% | 4,557,464 | 2.10B |
| 119 | PODD | Insulet Corporation | 9.13B | 0.69% | 3,060,814 | 3.05B |
| 120 | CYTK | Cytokinetics, Incorporated | 9.12B | -0.03% | 2,649,872 | 67.67M |
| 121 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.07B | -0.93% | 1,487,640 | 669.50M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 9.06B | 0.63% | 760,304 | 281.99M |
| 123 | KYMR | Kymera Therapeutics, Inc. | 8.93B | -2.48% | 870,206 | 105.00M |
| 124 | PCVX | Vaxcyte, Inc. | 8.40B | 0.77% | 2,399,638 | - |
| 125 | PRAX | Praxis Precision Medicines, Inc. | 8.25B | 3.00% | 456,099 | 7.46M |
| 126 | SYRE | Spyre Therapeutics, Inc. | 8.22B | 3.63% | 1,235,019 | - |
| 127 | ABVX | ABIVAX Société Anonyme | 8.19B | -2.33% | 644,376 | 5.33M |
| 128 | CAI | Caris Life Sciences, Inc. | 8.00B | -0.18% | 3,204,578 | 989.61M |
| 129 | HNGE | Hinge Health, Inc. | 7.88B | -0.28% | 975,349 | 720.06M |
| 130 | TGTX | TG Therapeutics, Inc. | 7.70B | 1.25% | 1,650,461 | 799.54M |
| 131 | ATR | AptarGroup, Inc. | 7.62B | -0.79% | 383,980 | 3.93B |
| 132 | HQY | HealthEquity, Inc. | 7.45B | 0.75% | 834,512 | 1.36B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.24B | -1.05% | 2,312,085 | 874.09M |
| 134 | AMRX | Amneal Pharmaceuticals, Inc. | 7.07B | 1.15% | 2,815,676 | 3.12B |
| 135 | ALKS | Alkermes plc | 7.00B | 2.98% | 2,423,456 | 1.67B |
| 136 | IMVT | Immunovant, Inc. | 6.94B | -0.09% | 1,022,191 | - |
| 137 | PACS | PACS Group, Inc. | 6.78B | 4.44% | 789,654 | 5.55B |
| 138 | HIMS | Hims & Hers Health, Inc. | 6.77B | -1.02% | 10,080,511 | 2.58B |
| 139 | CHE | Chemed Corporation | 6.61B | 0.91% | 159,123 | 2.60B |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.52B | 0.31% | 714,685 | 1.56B |
| 141 | IOVA | Iovance Biotherapeutics, Inc. | 6.44B | -0.11% | 11,922,401 | 324.97M |
| 142 | GRFS | Grifols, S.A. | 6.44B | 0.14% | 390,350 | 8.48B |
| 143 | BLTE | Belite Bio, Inc | 6.43B | -2.10% | 184,765 | - |
| 144 | GRAL | GRAIL, Inc. | 6.40B | 8.07% | 875,336 | 165.26M |
| 145 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.39B | -0.62% | 503,543 | 239.92M |
| 146 | BLCO | Bausch + Lomb Corporation | 6.11B | 1.00% | 354,099 | 5.32B |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.04B | 0.07% | 179,229 | 290.54M |
| 148 | CGON | CG Oncology, Inc. | 5.97B | -1.42% | 1,541,095 | 6.23M |
| 149 | KOD | Kodiak Sciences Inc. | 5.92B | -4.07% | 2,676,504 | - |
| 150 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.91B | 0.76% | 376,308 | 840.85M |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.70B | 1.41% | 1,238,585 | - |
| 152 | ORKA | Oruka Therapeutics, Inc. | 5.60B | 1.32% | 581,496 | - |
| 153 | MMED | MiniMed Group, Inc. | 5.54B | 0.51% | 4,695,066 | 3.22B |
| 154 | STVN | Stevanato Group S.p.A. | 5.52B | 1.10% | 189,923 | 1.40B |
| 155 | RDNT | RadNet, Inc. | 5.50B | 3.29% | 574,205 | 2.27B |
| 156 | MIRM | Mirum Pharmaceuticals, Inc. | 5.38B | -1.18% | 1,134,103 | 618.07M |
| 157 | COGT | Cogent Biosciences, Inc. | 5.38B | -1.80% | 1,172,135 | - |
| 158 | TVTX | Travere Therapeutics, Inc. | 5.37B | 0.14% | 1,722,066 | 591.33M |
| 159 | CRSP | CRISPR Therapeutics AG | 5.36B | -0.02% | 1,131,219 | 13.39M |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.30B | -1.04% | 895,554 | 1.01B |
| 161 | TFX | Teleflex Incorporated | 5.26B | -1.58% | 646,994 | 2.25B |
| 162 | SHC | Sotera Health Company | 5.20B | 0.55% | 2,081,192 | 1.22B |
| 163 | ERAS | Erasca, Inc. | 5.16B | 1.10% | 3,837,106 | - |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.10B | -0.91% | 492,413 | 1.58B |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.03B | -0.53% | 1,598,752 | - |
| 166 | BLLN | BillionToOne, Inc. | 5.00B | 0.13% | 418,298 | 397.41M |
| 167 | DOCS | Doximity, Inc. | 4.98B | -2.00% | 2,672,150 | 655.57M |
| 168 | DNTH | Dianthus Therapeutics, Inc. | 4.93B | -0.12% | 751,386 | 1.90M |
| 169 | MANE | Veradermics, Incorporated | 4.88B | -0.39% | 598,343 | - |
| 170 | HAE | Haemonetics Corporation | 4.76B | 0.30% | 328,574 | 1.35B |
| 171 | WAY | Waystar Holding Corp. | 4.76B | -2.13% | 1,688,631 | 1.21B |
| 172 | CON | Concentra Group Holdings Parent, Inc. | 4.55B | 1.94% | 1,381,617 | 2.29B |
| 173 | ADPT | Adaptive Biotechnologies Corporation | 4.52B | 3.58% | 1,575,446 | 308.08M |
| 174 | LFST | LifeStance Health Group, Inc. | 4.52B | -0.67% | 3,771,927 | 1.58B |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.50B | 2.27% | 1,459,615 | - |
| 176 | ABCL | AbCellera Biologics Inc. | 4.45B | -1.22% | 3,714,394 | 66.17M |
| 177 | ITGR | Integer Holdings Corporation | 4.30B | 0.02% | 471,808 | 1.84B |
| 178 | HTFL | HeartFlow, Inc. | 4.29B | 0.84% | 1,642,322 | 212.07M |
| 179 | INDV | Indivior Pharmaceuticals, Inc. | 4.21B | 0.93% | 1,669,266 | 1.33B |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.15B | 2.54% | 2,770,999 | 10.35M |
| 181 | LIVN | LivaNova PLC | 4.14B | 0.50% | 528,517 | 1.47B |
| 182 | ICUI | ICU Medical, Inc. | 3.99B | 1.40% | 227,671 | 2.16B |
| 183 | TNGX | Tango Therapeutics, Inc. | 3.92B | -4.95% | 5,253,910 | 53.81M |
| 184 | NVST | Envista Holdings Corporation | 3.77B | 1.30% | 2,345,233 | 2.86B |
| 185 | PBLS | Parabilis Medicines, Inc. | 3.74B | -0.53% | 881,231 | 148.00K |
| 186 | VCYT | Veracyte, Inc. | 3.68B | 3.67% | 1,041,729 | 561.90M |
| 187 | XENE | Xenon Pharmaceuticals Inc. | 3.68B | -2.34% | 1,939,068 | 7.50M |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.67B | -1.59% | 299,612 | 890.79M |
| 189 | IRTC | iRhythm Holdings, Inc. | 3.64B | -0.61% | 350,173 | 825.34M |
| 190 | IDYA | IDEAYA Biosciences, Inc. | 3.60B | -1.19% | 579,047 | 234.13M |
| 191 | OGN | Organon & Co. | 3.60B | 0.07% | 1,921,138 | 6.13B |
| 192 | LEGN | Legend Biotech Corporation | 3.60B | -3.88% | 2,529,587 | 1.27B |
| 193 | NHC | National HealthCare Corporation | 3.57B | 1.93% | 88,313 | 1.56B |
| 194 | CELC | Celcuity Inc. | 3.53B | -4.03% | 1,421,129 | - |
| 195 | VKTX | Viking Therapeutics, Inc. | 3.49B | -1.87% | 6,367,090 | - |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.49B | -1.03% | 912,395 | -665.00K |
| 197 | CDNA | CareDx, Inc. | 3.47B | 1.39% | 1,588,487 | 458.09M |
| 198 | ELVN | Enliven Therapeutics, Inc. | 3.44B | 1.64% | 1,123,209 | - |
| 199 | ACAD | Acadia Pharmaceuticals Inc. | 3.44B | 0.30% | 2,564,593 | 1.14B |
| 200 | PLSE | Pulse Biosciences, Inc. | 3.42B | -3.87% | 519,265 | 1.19M |
| 201 | OPCH | Option Care Health, Inc. | 3.39B | 0.27% | 1,263,368 | 5.69B |
| 202 | RGC | Regencell Bioscience Holdings Limited | 3.38B | 7.74% | 429,399 | - |
| 203 | WRBY | Warby Parker Inc. | 3.34B | -1.67% | 2,866,792 | 911.61M |
| 204 | TARS | Tarsus Pharmaceuticals, Inc. | 3.20B | -3.26% | 1,205,453 | 606.33M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.20B | -2.58% | 1,629,511 | 3.60M |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.16B | -0.51% | 1,778,472 | 463.98M |
| 207 | RCUS | Arcus Biosciences, Inc. | 3.11B | -3.13% | 1,041,907 | 117.00M |
| 208 | PGEN | Precigen, Inc. | 3.06B | 4.02% | 6,363,365 | 85.72M |
| 209 | DYN | Dyne Therapeutics, Inc. | 2.84B | -3.92% | 2,534,183 | - |
| 210 | MBX | MBX Biosciences, Inc. | 2.82B | 3.47% | 637,323 | - |
| 211 | ATRC | AtriCure, Inc. | 2.80B | 2.89% | 1,615,660 | 569.62M |
| 212 | NAMS | NewAmsterdam Pharma Company N.V. | 2.77B | -3.97% | 1,548,923 | 7.12M |
| 213 | TMDX | TransMedics Group, Inc. | 2.77B | 1.47% | 1,223,625 | 668.47M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.75B | 1.29% | 2,061,173 | 2.60B |
| 215 | ZLAB | Zai Lab Limited | 2.73B | -4.59% | 951,847 | 449.61M |
| 216 | GRDN | Guardian Pharmacy Services, Inc. | 2.68B | 3.77% | 542,339 | 1.46B |
| 217 | NEOG | Neogen Corporation | 2.65B | -0.74% | 2,877,890 | 870.40M |
| 218 | ACHC | Acadia Healthcare Company, Inc. | 2.61B | 4.20% | 1,444,101 | 3.37B |
| 219 | BKD | Brookdale Senior Living Inc. | 2.59B | 0.18% | 6,954,092 | 2.93B |
| 220 | PRVA | Privia Health Group, Inc. | 2.59B | 1.35% | 1,284,184 | 2.36B |
| 221 | LQDA | Liquidia Corporation | 2.56B | 2.32% | 8,404,137 | 450.91M |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.49B | -1.65% | 2,405,741 | 158.00K |
| 223 | IRON | Disc Medicine, Inc. | 2.48B | 1.41% | 684,730 | - |
| 224 | HCM | HUTCHMED (China) Limited | 2.47B | -2.54% | 45,737 | 549.12M |
| 225 | SUPN | Supernus Pharmaceuticals, Inc. | 2.46B | 0.47% | 739,805 | 830.44M |
| 226 | BEAM | Beam Therapeutics Inc. | 2.45B | 0.45% | 1,498,574 | 156.04M |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.39B | -1.50% | 815,509 | 36.77M |
| 228 | ALMR | Alamar Biosciences, Inc. | 2.38B | 5.85% | 339,922 | 100.42M |
| 229 | BFLY | Butterfly Network, Inc. | 2.38B | 4.92% | 4,489,324 | 112.14M |
| 230 | IMNM | Immunome, Inc. | 2.37B | 0.05% | 1,171,624 | 4.02M |
| 231 | NEO | NeoGenomics, Inc. | 2.37B | 3.88% | 2,302,423 | 766.30M |
| 232 | SLS | SELLAS Life Sciences Group, Inc. | 2.37B | 3.62% | 3,846,018 | - |
| 233 | UFPT | UFP Technologies, Inc. | 2.33B | 1.94% | 117,150 | 631.64M |
| 234 | CLOV | Clover Health Investments, Corp. | 2.33B | 3.55% | 3,859,212 | 2.48B |
| 235 | HRMY | Harmony Biosciences Holdings, Inc. | 2.31B | 0.18% | 916,734 | 959.90M |
| 236 | SDGR | Schrödinger, Inc. | 2.27B | -0.49% | 3,052,767 | 259.04M |
| 237 | RXRX | Recursion Pharmaceuticals, Inc. | 2.21B | 1.23% | 18,839,988 | 54.86M |
| 238 | VRDN | Viridian Therapeutics, Inc. | 2.20B | 2.16% | 1,515,408 | 71.13M |
| 239 | AXGN | Axogen, Inc. | 2.19B | -6.34% | 3,098,411 | 251.17M |
| 240 | VERA | Vera Therapeutics, Inc. | 2.19B | -1.84% | 1,614,860 | - |
| 241 | PHVS | Pharvaris N.V. | 2.19B | 0.58% | 591,392 | - |
| 242 | WGS | GeneDx Holdings Corp. | 2.18B | 3.00% | 606,696 | 454.43M |
| 243 | ADMA | ADMA Biologics, Inc. | 2.18B | -2.11% | 2,793,458 | 512.28M |
| 244 | BHC | Bausch Health Companies Inc. | 2.17B | 1.22% | 3,281,334 | 10.85B |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.14B | 1.09% | 543,299 | 1.10B |
| 246 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | -0.75% | 813,426 | 311.51M |
| 247 | MLYS | Mineralys Therapeutics, Inc. | 2.09B | -0.38% | 928,299 | - |
| 248 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.09B | 0.62% | 6,148,675 | 940.61M |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.06B | -1.38% | 2,269,200 | 1.14B |
| 250 | MD | Pediatrix Medical Group, Inc. | 2.06B | 0.82% | 616,416 | 1.95B |
| 251 | VCEL | Vericel Corporation | 2.06B | 1.80% | 479,214 | 306.30M |
| 252 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.05B | 5.33% | 1,913,829 | 208.78M |
| 253 | ADRX | ADARx Pharmaceuticals, Inc. | 2.05B | -6.60% | 937,067 | 6.13M |
| 254 | ADUS | Addus HomeCare Corporation | 2.04B | -0.38% | 207,746 | 1.48B |
| 255 | URGN | UroGen Pharma Ltd. | 2.02B | 2.10% | 604,961 | 188.73M |
| 256 | INSP | Inspire Medical Systems, Inc. | 2.02B | -1.14% | 761,930 | 898.74M |
| 257 | TRVI | Trevi Therapeutics, Inc. | 1.98B | -1.90% | 2,080,279 | - |
| 258 | PRGO | Perrigo Company plc | 1.98B | 1.71% | 2,168,945 | 4.14B |
| 259 | GPCR | Structure Therapeutics Inc. | 1.97B | -4.52% | 1,715,036 | - |
| 260 | ALVO | Alvotech | 1.95B | -3.02% | 750,933 | 494.61M |
| 261 | BHVN | Biohaven Ltd. | 1.94B | -2.05% | 1,735,503 | - |
| 262 | PGNY | Progyny, Inc. | 1.94B | 1.53% | 939,646 | 1.31B |
| 263 | ESTA | Establishment Labs Holdings Inc. | 1.91B | 1.62% | 309,228 | 245.82M |
| 264 | PVLA | Palvella Therapeutics, Inc. | 1.91B | -0.20% | 348,127 | - |
| 265 | FTRE | Fortrea Holdings Inc. | 1.90B | 3.09% | 1,186,212 | 2.68B |
| 266 | ABSI | Absci Corporation | 1.90B | 2.98% | 3,384,933 | 1.56M |
| 267 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | -2.09% | 569,935 | 98.34M |
| 268 | VIR | Vir Biotechnology, Inc. | 1.89B | -1.06% | 2,180,670 | 303.23M |
| 269 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 1.77% | 270,234 | 1.13B |
| 270 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -0.40% | 2,549,724 | 1.97B |
| 271 | XNCR | Xencor, Inc. | 1.85B | 0.28% | 1,097,641 | 104.97M |
| 272 | ZBIO | Zenas BioPharma, Inc. | 1.84B | 1.27% | 1,513,617 | 1.00M |
| 273 | ASTH | Astrana Health, Inc. | 1.84B | 2.78% | 310,359 | 3.84B |
| 274 | MESO | Mesoblast Limited | 1.83B | -1.68% | 265,208 | 120.25M |
| 275 | BLFS | BioLife Solutions, Inc. | 1.82B | 1.41% | 2,847,269 | 106.69M |
| 276 | LMAT | LeMaitre Vascular, Inc. | 1.81B | -1.53% | 325,685 | 262.43M |
| 277 | NUVB | Nuvation Bio Inc. | 1.80B | -7.55% | 14,830,275 | 169.90M |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.79B | -0.19% | 532,879 | 481.07M |
| 279 | ZYME | Zymeworks Inc. | 1.78B | -3.12% | 844,446 | 37.13M |
| 280 | SEPN | Septerna, Inc. | 1.76B | -0.89% | 395,449 | 98.88M |
| 281 | GENB | Generate Biomedicines, Inc. | 1.76B | -0.80% | 1,263,168 | 26.48M |
| 282 | BRVE | Braveheart Bio, Inc. | 1.75B | -0.65% | 462,790 | - |
| 283 | FRNM | Freenome, Inc. | 1.75B | 4.35% | 813,566 | 35.41M |
| 284 | NVCR | NovoCure Limited | 1.74B | -6.16% | 1,695,114 | 699.19M |
| 285 | PSNL | Personalis, Inc. | 1.74B | 0.68% | 1,139,121 | 69.67M |
| 286 | XRAY | DENTSPLY SIRONA Inc. | 1.73B | -0.80% | 5,786,403 | 3.64B |
| 287 | SGRY | Surgery Partners, Inc. | 1.73B | 0.68% | 1,228,073 | 3.37B |
| 288 | NVAX | Novavax, Inc. | 1.73B | -1.32% | 4,025,442 | 413.80M |
| 289 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 1.16% | 4,503,688 | 59.51M |
| 290 | AZTA | Azenta, Inc. | 1.70B | 12.38% | 3,384,486 | 613.81M |
| 291 | XERS | Xeris Biopharma Holdings, Inc. | 1.66B | -1.84% | 1,803,575 | 335.41M |
| 292 | STOK | Stoke Therapeutics, Inc. | 1.65B | -1.50% | 848,622 | 27.59M |
| 293 | CMPS | COMPASS Pathways plc | 1.65B | -0.42% | 2,664,422 | - |
| 294 | ALHC | Alignment Healthcare, Inc. | 1.65B | 2.58% | 9,805,567 | 4.58B |
| 295 | KMTS | Kestra Medical Technologies, Ltd. | 1.63B | 1.14% | 254,764 | 106.73M |
| 296 | QURE | uniQure N.V. | 1.63B | 0.39% | 1,953,135 | 18.67M |
| 297 | ETON | Eton Pharmaceuticals, Inc. | 1.58B | 6.50% | 750,078 | 105.60M |
| 298 | GHRS | GH Research PLC | 1.57B | 0.35% | 230,107 | - |
| 299 | SNDX | Syndax Pharmaceuticals, Inc. | 1.57B | -3.40% | 2,557,963 | 252.25M |
| 300 | ATEC | Alphatec Holdings, Inc. | 1.55B | 1.31% | 2,189,834 | 815.05M |
| 301 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | -1.07% | 309,509 | 978.38M |
| 302 | RAPP | Rapport Therapeutics, Inc. | 1.54B | -2.01% | 277,627 | 20.00M |
| 303 | OMCL | Omnicell, Inc. | 1.53B | 0.48% | 344,496 | 1.25B |
| 304 | IMCR | Immunocore Holdings plc | 1.53B | -2.72% | 657,606 | 430.78M |
| 305 | OCUL | Ocular Therapeutix, Inc. | 1.53B | -4.53% | 4,958,198 | 52.06M |
| 306 | PAHC | Phibro Animal Health Corporation | 1.51B | 3.82% | 222,744 | 1.52B |
| 307 | TSHA | Taysha Gene Therapies, Inc. | 1.51B | -2.32% | 2,990,160 | 5.49M |
| 308 | RARE | Ultragenyx Pharmaceutical Inc. | 1.50B | 3.19% | 3,880,768 | 717.00M |
| 309 | NKTR | Nektar Therapeutics | 1.49B | -7.26% | 2,923,413 | 54.59M |
| 310 | NUTX | Nutex Health Inc. | 1.48B | 1.97% | 297,131 | 846.72M |
| 311 | INVA | Innoviva, Inc. | 1.48B | -0.24% | 774,707 | 440.00M |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.47B | -0.83% | 633,046 | 20.00M |
| 313 | ARDT | Ardent Health, Inc. | 1.46B | 0.88% | 280,601 | 6.41B |
| 314 | COAG | Hemab Therapeutics Holdings, Inc. | 1.45B | 0.16% | 354,148 | - |
| 315 | ANAB | AnaptysBio, Inc. | 1.45B | -0.21% | 441,125 | 106.09M |
| 316 | HCSG | Healthcare Services Group, Inc. | 1.43B | 1.41% | 597,938 | 1.86B |
| 317 | CERT | Certara, Inc. | 1.43B | 0.21% | 2,646,000 | 421.75M |
| 318 | INBX | Inhibrx Biosciences, Inc. | 1.43B | -0.96% | 201,448 | 1.30M |
| 319 | AMN | AMN Healthcare Services, Inc. | 1.42B | 2.15% | 887,175 | 3.43B |
| 320 | AGL | agilon health, inc. | 1.41B | 2.26% | 205,149 | 5.92B |
| 321 | TYRA | Tyra Biosciences, Inc. | 1.40B | -2.76% | 1,047,668 | - |
| 322 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -2.28% | 507,603 | - |
| 323 | KRSA | Korsana Biosciences, Inc. | 1.39B | -2.28% | 51,667 | - |
| 324 | CNMD | CONMED Corporation | 1.39B | 0.85% | 240,741 | 1.37B |
| 325 | KARD | Kardigan, Inc. | 1.38B | 3.79% | 524,504 | - |
| 326 | PNTG | The Pennant Group, Inc. | 1.37B | 1.16% | 254,631 | 1.10B |
| 327 | AAPG | Ascentage Pharma Group International | 1.37B | -3.36% | 8,995 | 94.61M |
| 328 | DRTS | Alpha Tau Medical Ltd. | 1.36B | 1.79% | 307,406 | - |
| 329 | OMER | Omeros Corporation | 1.35B | 0.76% | 956,393 | 38.42M |
| 330 | KLRA | Kailera Therapeutics, Inc. | 1.35B | -5.80% | 1,283,603 | - |
| 331 | NBTX | Nanobiotix S.A. | 1.31B | -7.71% | 255,770 | 13.15M |
| 332 | DMRA | Damora Therapeutics, Inc. | 1.27B | 2.08% | 692,890 | - |
| 333 | ORIC | ORIC Pharmaceuticals, Inc. | 1.27B | -2.52% | 1,232,085 | - |
| 334 | USPH | U.S. Physical Therapy, Inc. | 1.25B | 1.36% | 239,782 | 804.27M |
| 335 | AVLN | Avalyn Pharma Inc. | 1.25B | 2.59% | 526,200 | - |
| 336 | OMDA | Omada Health, Inc. | 1.25B | -0.20% | 1,245,026 | 309.76M |
| 337 | REPL | Replimune Group, Inc. | 1.23B | -2.83% | 1,302,971 | - |
| 338 | INNV | InnovAge Holding Corp. | 1.22B | 1.82% | 1,178,402 | 989.71M |
| 339 | SVRA | Savara Inc. | 1.22B | -4.75% | 2,653,328 | - |
| 340 | MNKD | MannKind Corporation | 1.22B | -3.80% | 4,610,310 | 393.63M |
| 341 | LBRX | LB Pharmaceuticals Inc | 1.19B | -0.78% | 388,886 | - |
| 342 | CRON | Cronos Group Inc. | 1.19B | 0.47% | 1,236,549 | 179.09M |
| 343 | TRAX | First Tracks Biotherapeutics, Inc. | 1.19B | -1.89% | 1,167,886 | - |
| 344 | BCAX | Bicara Therapeutics Inc. | 1.17B | -3.13% | 763,074 | - |
| 345 | OPK | OPKO Health, Inc. | 1.16B | -0.64% | 1,398,989 | 587.90M |
| 346 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | - | 2,194,632 | 1.04B |
| 347 | HROW | Harrow, Inc. | 1.14B | -0.42% | 566,383 | 275.59M |
| 348 | STAA | STAAR Surgical Company | 1.13B | 0.40% | 640,038 | 339.59M |
| 349 | GDRX | GoodRx Holdings, Inc. | 1.12B | 0.31% | 860,468 | 785.23M |
| 350 | VOR | Vor Biopharma Inc. | 1.11B | 3.49% | 773,270 | - |
| 351 | BVS | Bioventus Inc. | 1.10B | -2.38% | 362,372 | 581.85M |
| 352 | IRMD | IRADIMED CORPORATION | 1.09B | 0.12% | 119,454 | 86.34M |
| 353 | AORT | Artivion, Inc. | 1.09B | 1.73% | 559,448 | 471.47M |
| 354 | CSTL | Castle Biosciences, Inc. | 1.09B | 0.85% | 167,719 | 357.28M |
| 355 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.08B | 0.32% | 374,220 | 730.02M |
| 356 | LTGO | Latigo Biotherapeutics, Inc. | 1.05B | -4.73% | 276,567 | - |
| 357 | IMTX | Immatics N.V. | 1.04B | -10.07% | 1,256,981 | 47.65M |
| 358 | MGTX | MeiraGTx Holdings plc | 1.04B | 1.22% | 820,038 | 397.50M |
| 359 | JANX | Janux Therapeutics, Inc. | 1.04B | -0.18% | 805,266 | 24.00M |
| 360 | AKTS | Aktis Oncology, Inc. | 1.03B | - | 337,989 | 10.06M |
| 361 | ENOV | Enovis Corporation | 1.02B | -1.55% | 1,366,896 | 2.30B |
| 362 | PCRX | Pacira BioSciences, Inc. | 1.00B | 0.80% | 469,795 | 746.16M |
| 363 | TDOC | Teladoc Health, Inc. | 1.00B | -2.65% | 4,891,903 | 2.49B |
| 364 | CGEM | Cullinan Therapeutics, Inc. | 998.14M | 6.74% | 1,162,136 | - |
| 365 | BBNX | Beta Bionics, Inc. | 998.09M | 0.48% | 515,082 | 119.01M |
| 366 | ODTX | Odyssey Therapeutics, Inc. | 993.11M | 1.49% | 192,503 | 99.00K |
| 367 | LMRI | Lumexa Imaging Holdings, Inc. | 991.49M | 2.18% | 476,422 | 1.04B |
| 368 | IART | Integra LifeSciences Holdings Corporation | 986.16M | -21.19% | 2,695,971 | 1.65B |
| 369 | SPTX | Seaport Therapeutics, Inc. | 986.03M | -2.80% | 258,703 | - |
| 370 | AHG | Akso Health Group | 985.21M | 12.75% | 82,357 | 13.83M |
| 371 | PRCT | PROCEPT BioRobotics Corporation | 982.82M | 0.82% | 1,240,858 | 337.34M |
| 372 | ANRO | Alto Neuroscience, Inc. | 973.20M | -2.02% | 660,691 | - |
| 373 | ANL | Adlai Nortye Group Ltd. | 971.76M | -4.25% | 77,003 | 18.06M |
| 374 | MLTX | MoonLake Immunotherapeutics | 971.07M | -0.52% | 1,827,970 | - |
| 375 | KURA | Kura Oncology, Inc. | 947.43M | - | 1,887,300 | 77.23M |
| 376 | HSTM | HealthStream, Inc. | 942.97M | 1.52% | 155,946 | 321.12M |
| 377 | CRVS | Corvus Pharmaceuticals, Inc. | 916.92M | -0.27% | 1,347,819 | - |
| 378 | CBLL | CeriBell, Inc. | 909.18M | 0.34% | 307,032 | 101.96M |
| 379 | JBIO | Jade Biosciences, Inc. | 898.00M | 2.54% | 1,109,846 | - |
| 380 | GLUE | Monte Rosa Therapeutics, Inc. | 895.79M | -6.75% | 2,214,535 | 28.73M |
| 381 | APMD | Apnimed, Inc. | 895.48M | -4.57% | 682,086 | 115.12M |
| 382 | SLBT | SL Science Holding Limited | 895.32M | -1.88% | 52,275 | 3.27M |
| 383 | ALMS | Alumis Inc. | 886.63M | -4.99% | 2,624,796 | 7.40M |
| 384 | RIGL | Rigel Pharmaceuticals, Inc. | 880.76M | 0.38% | 185,674 | 276.79M |
| 385 | ABUS | Arbutus Biopharma Corporation | 880.42M | -2.41% | 8,987,366 | 181.72M |
| 386 | SANA | Sana Biotechnology, Inc. | 865.15M | - | 3,498,446 | - |
| 387 | HELP | Helus Pharma Inc. | 854.80M | -1.76% | 1,407,757 | - |
| 388 | OBX | Obsidian Therapeutics, Inc. | 839.49M | 2.03% | 228,988 | - |
| 389 | IVA | Inventiva S.A. | 836.35M | 2.89% | 4,886,119 | 2.81M |
| 390 | SGP | SpyGlass Pharma, Inc. | 833.52M | -5.96% | 142,059 | - |
| 391 | ARDX | Ardelyx, Inc. | 832.29M | -1.18% | 4,092,152 | 450.89M |
| 392 | DNA | Ginkgo Bioworks Holdings, Inc. | 831.65M | -1.20% | 2,041,280 | 132.42M |
| 393 | SIBN | SI-BONE, Inc. | 810.32M | -1.79% | 547,323 | 213.60M |
| 394 | INMD | InMode Ltd. | 809.90M | 0.28% | 616,358 | 374.63M |
| 395 | LXRX | Lexicon Pharmaceuticals, Inc. | 809.82M | - | 2,317,716 | 41.47M |
| 396 | AVTX | Avalo Therapeutics, Inc. | 803.91M | 0.27% | 948,519 | 59.00K |
| 397 | IMMX | Immix Biopharma, Inc. | 802.50M | -5.38% | 2,548,188 | - |
| 398 | ANNX | Annexon, Inc. | 794.34M | 1.70% | 4,019,804 | - |
| 399 | PACB | Pacific Biosciences of California, Inc. | 789.51M | 1.20% | 26,011,242 | 159.27M |
| 400 | ATTO | Attovia Therapeutics, Inc. | 783.83M | -3.49% | 348,657 | 1.80M |
| 401 | CADL | Candel Therapeutics, Inc. | 778.96M | 0.20% | 878,803 | - |
| 402 | VREX | Varex Imaging Corporation | 778.05M | -0.16% | 373,735 | 865.00M |
| 403 | DSGN | Design Therapeutics, Inc. | 772.26M | 0.82% | 565,846 | - |
| 404 | GERN | Geron Corporation | 770.97M | -0.83% | 14,719,671 | 204.56M |
| 405 | GMRS | GMR Solutions Inc. | 768.67M | 4.99% | 1,182,579 | 5.88B |
| 406 | CTKB | Cytek Biosciences, Inc. | 763.00M | 1.03% | 1,099,465 | 206.71M |
| 407 | FDMT | 4D Molecular Therapeutics, Inc. | 755.19M | -1.23% | 1,036,924 | 92.01M |
| 408 | GYRE | Gyre Therapeutics, Inc. | 753.90M | 1.57% | 163,747 | 109.82M |
| 409 | AVR | Anteris Technologies Global Corp. | 751.67M | 1.31% | 1,495,587 | 2.24M |
| 410 | AHCO | AdaptHealth Corp. | 747.09M | -1.41% | 1,733,578 | 3.36B |
| 411 | ACHV | Achieve Life Sciences, Inc. | 745.01M | -3.85% | 1,886,305 | - |
| 412 | WVE | Wave Life Sciences, Inc. | 744.84M | -2.58% | 3,745,021 | 65.37M |
| 413 | QDEL | QuidelOrtho Corporation | 738.56M | 3.76% | 2,417,486 | 2.67B |
| 414 | SLDB | Solid Biosciences Inc. | 734.49M | -1.86% | 1,198,190 | - |
| 415 | FTH | Faeth Therapeutics, Inc. | 732.58M | 0.28% | 187,923 | - |
| 416 | OLMA | Olema Pharmaceuticals, Inc. | 719.67M | -0.54% | 1,071,939 | - |
| 417 | COLL | Collegium Pharmaceutical, Inc. | 716.87M | 0.82% | 694,061 | 808.21M |
| 418 | NVCT | Nuvectis Pharma, Inc. | 714.19M | 5.79% | 207,522 | - |
| 419 | OABI | OmniAb, Inc. | 708.05M | -2.40% | 1,623,653 | 38.46M |
| 420 | VSTM | Verastem, Inc. | 697.34M | -2.53% | 4,071,839 | 87.53M |
| 421 | PHAR | Pharming Group N.V. | 693.20M | -2.01% | 12,408 | 366.48M |
| 422 | SOPH | SOPHiA GENETICS SA | 686.98M | 0.50% | 748,036 | 86.17M |
| 423 | STTK | Shattuck Labs, Inc. | 675.44M | -1.61% | 1,843,744 | 1.00M |
| 424 | MDXG | MiMedx Group, Inc. | 669.04M | -1.08% | 1,370,319 | 355.17M |
| 425 | ETRA | Electra Therapeutics, Inc. | 650.89M | -2.90% | 696,581 | - |
| 426 | SGMT | Sagimet Biosciences Inc. | 648.11M | -2.45% | 1,712,552 | - |
| 427 | STLN | Starling Oncology, Inc. | 647.17M | 2.09% | 793,879 | 587.24M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 646.20M | -0.45% | 6,208,853 | 8.22M |
| 429 | SLN | Silence Therapeutics plc | 640.63M | -0.65% | 973,327 | 615.00K |
| 430 | DBVT | DBV Technologies S.A. | 634.13M | -5.89% | 673,301 | 5.04M |
| 431 | AURA | Aura Biosciences, Inc. | 631.56M | 0.83% | 2,099,065 | - |
| 432 | CLYM | Climb Bio, Inc. | 628.35M | -1.17% | 1,575,012 | - |
| 433 | BLSM | BlossomHill Therapeutics, Inc. | 625.84M | 5.92% | 169,327 | - |
| 434 | PHR | Phreesia, Inc. | 625.05M | -2.80% | 528,825 | 507.79M |
| 435 | ANGO | AngioDynamics, Inc. | 624.53M | -0.07% | 1,128,003 | 320.17M |
| 436 | CBIO | Crescent Biopharma, Inc. | 612.91M | 0.42% | 283,271 | 11.88M |
| 437 | IRWD | Ironwood Pharmaceuticals, Inc. | 601.47M | -3.19% | 2,700,619 | 389.32M |
| 438 | ZVRA | Zevra Therapeutics, Inc. | 593.24M | -1.87% | 951,870 | 136.07M |
| 439 | FLGT | Fulgent Genetics, Inc. | 591.03M | 0.85% | 297,613 | 323.93M |
| 440 | WEAV | Weave Communications, Inc. | 589.59M | -0.14% | 730,249 | 257.79M |
| 441 | EVO | Evotec SE | 584.16M | -2.74% | 52,035 | 819.47M |
| 442 | KIDS | OrthoPediatrics Corp. | 578.59M | 2.17% | 150,274 | 252.72M |
| 443 | YDES | YD Bio Limited | 574.44M | 3.84% | 546,622 | 1.24M |
| 444 | AQST | Aquestive Therapeutics, Inc. | 571.08M | 2.48% | 2,272,519 | 54.09M |
| 445 | CRMD | CorMedix Inc. | 560.42M | -3.10% | 1,125,335 | 462.25M |
| 446 | CTMX | CytomX Therapeutics, Inc. | 557.82M | -2.66% | 2,624,133 | 18.30M |
| 447 | PHAT | Phathom Pharmaceuticals, Inc. | 549.66M | -2.26% | 1,683,811 | 239.66M |
| 448 | MPLT | MapLight Therapeutics, Inc. | 545.75M | 1.97% | 565,742 | - |
| 449 | VALN | Valneva SE | 540.23M | -2.71% | 39,844 | 163.30M |
| 450 | OCS | Oculis Holding AG | 538.92M | -0.34% | 586,304 | 1.45M |
| 451 | SSII | SS Innovations International, Inc. | 535.03M | -2.91% | 51,272 | 52.40M |
| 452 | ALT | Altimmune, Inc. | 532.01M | -0.91% | 4,252,719 | 31.00K |
| 453 | PRME | Prime Medicine, Inc. | 530.15M | -0.33% | 2,109,997 | 4.07M |
| 454 | DCTH | Delcath Systems, Inc. | 524.99M | -1.82% | 436,637 | 95.42M |
| 455 | MASS | 908 Devices Inc. | 524.52M | 1.44% | 411,384 | 60.84M |
| 456 | MNPR | Monopar Therapeutics Inc. | 523.35M | - | 107,623 | - |
| 457 | SENS | Senseonics Holdings, Inc. | 522.40M | -0.80% | 705,953 | 48.55M |
| 458 | CAPR | Capricor Therapeutics, Inc. | 520.34M | 0.11% | 2,638,977 | 11.13M |
| 459 | PROK | ProKidney Corp. | 519.99M | 0.58% | 1,089,632 | 818.00K |
| 460 | ALLO | Allogene Therapeutics, Inc. | 518.24M | -2.60% | 4,656,621 | 4.64M |
| 461 | GLAS | Glass House Brands Inc. | 517.39M | 3.20% | 1,406,244 | 176.98M |
| 462 | NGNE | Neurogene Inc. | 513.29M | -3.39% | 401,641 | 925.00K |
| 463 | BWAY | BrainsWay Ltd. | 506.80M | -0.79% | 50,830 | 60.70M |
| 464 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 465 | TCMD | Tactile Systems Technology, Inc. | 500.62M | 1.80% | 252,306 | 350.31M |
| 466 | ENTX | Entera Bio Ltd. | 495.19M | -1.04% | 100,701 | 42.00K |
| 467 | TLRY | Tilray Brands, Inc. | 494.54M | 1.12% | 4,132,920 | 915.45M |
| 468 | CTNM | Contineum Therapeutics, Inc. | 493.59M | 1.00% | 794,261 | - |
| 469 | PBYI | Puma Biotechnology, Inc. | 490.91M | -3.35% | 454,882 | 231.24M |
| 470 | RGNX | REGENXBIO Inc. | 490.48M | 0.13% | 1,036,886 | 174.48M |
| 471 | DRUG | Bright Minds Biosciences Inc. | 488.45M | 3.01% | 154,901 | - |
| 472 | ARVN | Arvinas, Inc. | 484.51M | -0.27% | 585,123 | 316.70M |
| 473 | TKNO | Alpha Teknova, Inc. | 482.66M | 1.47% | 249,324 | 43.70M |
| 474 | EPRX | Eupraxia Pharmaceuticals Inc. | 477.13M | -7.54% | 1,714,357 | - |
| 475 | KMDA | Kamada Ltd. | 475.28M | 1.34% | 57,878 | 191.85M |
| 476 | AUTL | Autolus Therapeutics plc | 473.77M | -3.78% | 1,811,775 | 117.39M |
| 477 | EOLS | Evolus, Inc. | 471.60M | -7.15% | 2,070,873 | 316.49M |
| 478 | SGHT | Sight Sciences, Inc. | 469.90M | -5.54% | 398,476 | 83.38M |
| 479 | OVID | Ovid Therapeutics Inc. | 464.81M | -2.06% | 2,173,692 | 1.58M |
| 480 | CERS | Cerus Corporation | 459.48M | -1.72% | 1,751,626 | 221.55M |
| 481 | ASMB | Assembly Biosciences, Inc. | 458.93M | -1.91% | 368,313 | 74.85M |
| 482 | NRC | NRC Health | 450.13M | -4.55% | 124,153 | 140.00M |
| 483 | DMAC | DiaMedica Therapeutics Inc. | 443.81M | -1.44% | 335,683 | - |
| 484 | TECX | Tectonic Therapeutic, Inc. | 440.64M | -0.57% | 253,433 | - |
| 485 | NPCE | NeuroPace, Inc. | 435.92M | -3.42% | 120,419 | 106.99M |
| 486 | MYGN | Myriad Genetics, Inc. | 434.25M | 11.82% | 2,281,250 | 806.60M |
| 487 | PRTA | Prothena Corporation plc | 429.18M | -2.11% | 675,839 | 54.53M |
| 488 | AGMB | AgomAb Therapeutics NV | 421.56M | -1.04% | 391,631 | - |
| 489 | RZLT | Rezolute, Inc. | 420.64M | -1.47% | 1,646,388 | - |
| 490 | SRTA | Strata Critical Medical, Inc. | 418.45M | -2.07% | 999,670 | 255.98M |
| 491 | AVIR | Atea Pharmaceuticals, Inc. | 411.45M | 0.59% | 253,264 | - |
| 492 | SPRY | ARS Pharmaceuticals, Inc. | 404.75M | -1.21% | 1,828,672 | 116.93M |
| 493 | EDIT | Editas Medicine, Inc. | 402.38M | 3.97% | 2,162,809 | 47.01M |
| 494 | CTEV | Claritev Corporation | 401.99M | 11.31% | 228,899 | 994.67M |
| 495 | TTRX | Turn Therapeutics Inc. | 397.07M | 0.15% | 136,299 | - |
| 496 | EIKN | Eikon Therapeutics, Inc. | 397.03M | -1.08% | 420,378 | - |
| 497 | SI | Shoulder Innovations, Inc. | 395.77M | 1.39% | 144,353 | 60.06M |
| 498 | ZURA | Zura Bio Limited | 393.86M | -0.72% | 2,954,783 | - |
| 499 | RCEL | AVITA Medical, Inc. | 393.39M | 5.91% | 391,214 | 75.63M |
| 500 | GALT | Galectin Therapeutics Inc. | 393.31M | 3.72% | 220,511 | - |